Vertically Integrated Multifamily Real Estate Developer with Asset & Property Management Platforms
Come join the Family Office Networks Webinar Series featuring Bel Canto Asset Growth Fund.
Bel Canto is a vertically integrated apartment development, asset and property management company headquartered in Greater Philadelphia with a national footprint from Seattle, WA, to Jacksonville, FL. The Bel Canto family office has an immediate pipeline of approximately $400M in total project costs consisting of new construction garden and mid-rise apartment developments and select value-add investments.
Thomas A. Leonard, Esq., Bel Canto’s Founding Partner and Chairman, and Jennifer A. Nevitt, Partner and CEO, will discuss how they operate Bel Canto Asset Growth Fund as a boutique apartment development company in conjunction with its property management counterpart, Forty-Two LLC. Working cohesively, the fundamentals of focused fiduciary responsibility actions and value creation strategies achieve exceptional and consistent returns.
Our investment strategy is focused on the operator first followed by states with preferred regulatory environments and premiere assets. By focusing on operators who are among the best managed and well-funded that operate in states with competitive advantage and high-quality assets, we believe we can build a portfolio of superior returns and minimal risk.
Freehold continues to attract qualified investors to execute on our actionable pipeline that is well positioned to capitalize on the immediate short-term dislocation in pricing from dearth of institutional capital available to cannabis operators seeking funding to continue their significant growth momentum.
The opportunity in Freehold Properties provides for immediate investment in a real estate company with:
Established partnerships with best-in-class cannabis operator-tenants
Strong upside returns via cap rate compression and well-developed path to public markets
Attractive initial portfolio
Actionable pipeline and growing operator relationships
Fast growing industry, proven management team and experienced board.
PYC Therapeutics Delivering the Potential of Precision Medicine
PYC is using its expertise in RNA drug design and proprietary drug delivery technology to bring a powerful new class of precision medicine to patients. With an initial focus on rare eye disease, PYC’s technology has the potential to unlock treatments for multiple types of genetic disease.
The company has proven the efficacy and safety of its lead drug program in patient-derived models and has launched formal studies in preparation for human clinical trials in 2021.
Life Settlement Longevity-Based Investing
Come join the Family Office Networks Webinar Series Featuring AIR Asset Management. AIRAM advises and manages investment vehicles that provide unique opportunities within the alternative investment space to qualified investors. AIRAM focuses on life settlements and other longevity-linked investment products.
Richard Beleutz, Chief Executive Officer and Scott Romanek, Managing Director of Sales & Marketing will discuss how they leverage the proficiency and experience of an extensive network of strategic partners to deploy investment strategies.
Multifamily Apartments Institutional Quality Private Real Estate Investments
Timberland Partners is a Minneapolis-based real estate investment and management company focused exclusively on the multifamily apartment sector. In business for over 28 years, Timberland Partners owns and operates a +17,000-unit, $2 billion portfolio across the central and southeastern United States. The company specializes in value-add investments across growing secondary and tertiary markets.
Timberland Partners has recently scheduled their second capital closing for their 7th multi-asset apartment fund, as total commitments have reached $50 million.
The company has identified and placed under contact two additional assets in exciting markets that should be excellent cash producers for the fund.
Despite the downturn in the economy, Timberland Partners’ portfolio of properties has improved operating income year-to-date by over 6.7% – despite operating through a global pandemic – proving the resiliency of the multifamily sector with best-in-class management and creating value for their investment partners.
OXIO Health: Looking to Profit from a Post Covid Healthcare
The experienced team at OXIO have developed key elements of the technology and innovation to bring meaningful and needed change across the entire healthcare delivery continuum for Babies to Baby Boomers. The annual recurring revenue (APR) potential is staggering. The “technology-infused” care they have developed along with an innovative financial model is designed to bring recurring reward to their investors.
Richard Taittinger Gallery: ART + LUXURY + TECH
The Webinar will feature Founder and CEO Richard Frerejean Taittinger, great-grandson of the CHAMPAGNE TAITTINGER founder, whose tech-savvy Lower East Side New York gallery focuses on emerging and mid-career artists with global recognition. RTG is finishing the final half of its $3 million expansion round to bolster its online platform and for general working capital. RTG has already raised approximately 50% of its target from new and existing investors, including the Harvard Business School Alumni Angels.
EPS Holdings: Welcome the Power Generation for the next Generation
EPS is a privately held, technology driven company that is focused on developing new power solutions for the Next Generation through the manufacturing of highly efficient, re-engineered, small sized turbine engines for use in the Distributed Energy sector – where end users of power effectively “get off the power grid”.
ReliantID is a consumer-focused healthcare company on a mission to engineer, design, and build tools that connect patients with providers for real-time diagnosis and treatment.
Innovative Medicine Partners: New Fertility Solutions
Innovative Medicine Partners is a dynamic, collaborative network of medical visionaries working in collaboration to develop novel medical devices. Our expert team of clinicians, scientists, engineers, legal advisors, regulatory specialists, marketing and financial professionals possesses an unparalleled level of experience in all aspects required to bring medical devices from concept to commercialization.ReliantID is a consumer-focused healthcare company on a mission to engineer, design, and build tools that connect patients with providers for real-time diagnosis and treatment.
MDBOX The Future of Healthcare Enhanced Telemedicine
MDBox enhanced telemedicine app is the company’s core platform – it uses A.I. and machine vision to integrate diagnostic tests, triage patients, and soon, will offer remote patient monitoring, personal health data tracking, and contact tracing. Patients use their smartphone device to initiate medical visits for triage, testing, diagnosis, and treatment 24/7/365.
ReliantID is a consumer-focused healthcare company on a mission to engineer, design, and build tools that connect patients with providers for real-time diagnosis and treatment.
HUVR The Future of Travel in a Pandemic World
Huvr Travelers can visit any city by virtually teleporting into a Huvr Walker in real time for an unprecedented safe and affordable travel experience where they have full control over where they go, what they see and when they see it. Huvr uses a two-sided marketplace similar to popular ride sharing apps like Uber and Lift, which means we will be creating much needed jobs around the world, within the “new normal” paradigm, while generating a very nice margin for our company and investors.